Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs

Introduction: Acromegaly is a rare, serious endocrine disorder characterized by excess growth hormone (GH) secretion by a pituitary adenoma and overproduction of insulin-like growth factor I (IGF-I). Transsphenoidal surgery is the treatment of choice, although many patients require additional interv...

Descripción completa

Detalles Bibliográficos
Autores principales: Gadelha, Mônica, Bex, Marie, Colao, Annamaria, Pedroza García, Elier Mitsael, Poiana, Catalina, Jimenez-Sanchez, Marisela, Yener, Serkan, Mukherjee, Rishav, Bartalotta, Amy, Maamari, Ricardo, Raverot, Gérald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008501/
https://www.ncbi.nlm.nih.gov/pubmed/32117045
http://dx.doi.org/10.3389/fendo.2019.00931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008501/
https://www.ncbi.nlm.nih.gov/pubmed/32117045
http://dx.doi.org/10.3389/fendo.2019.00931

Ejemplares similares